Filipa Lynce, MD, director of Dana-Farber's Inflammatory Breast Program and Sara Tolaney, MD, MPH, chief of the Division of Breast Oncology, welcome attendees to the Dana-Farber Inflammatory Breast Cancer Program 5th Annual Patient Forum in April 2022 and provide an update on research and treatment advances within the IBC Program.
For more information about Dana-Farber's Inflammatory Breast Cancer Program, please visit us at https://www.dana-farber.org/inflammatory-breast-cancer-program.